Post hoc analysis of SCORED trial sheds positive light on Inpefa for heart failure

According to a post hoc analysis of the SCORED study, the use of Inpefa was shown to reduce the risk of total cardiovascular (CV) deaths, hospitalisations, or urgent visits by 29% compared to placebo.